190 related articles for article (PubMed ID: 32263517)
1. Nanoparticle delivery systems for siRNA-based therapeutics.
Li J; Xue S; Mao ZW
J Mater Chem B; 2016 Nov; 4(41):6620-6639. PubMed ID: 32263517
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in nanoparticle-based siRNA delivery for cancer therapy.
Lee JM; Yoon TJ; Cho YS
Biomed Res Int; 2013; 2013():782041. PubMed ID: 23844368
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
Ku SH; Kim K; Choi K; Kim SH; Kwon IC
Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges.
Zhou J; Shum KT; Burnett JC; Rossi JJ
Pharmaceuticals (Basel); 2013; 6(1):85-107. PubMed ID: 23667320
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of short interfering RNAs--strategies for in vivo delivery.
Wullner U; Neef I; Tur MK; Barth S
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):1-8. PubMed ID: 19149683
[TBL] [Abstract][Full Text] [Related]
6. Chemical and structural modifications of RNAi therapeutics.
Ku SH; Jo SD; Lee YK; Kim K; Kim SH
Adv Drug Deliv Rev; 2016 Sep; 104():16-28. PubMed ID: 26549145
[TBL] [Abstract][Full Text] [Related]
7. [Research progress on the development of the strategies for siRNAs delivery in vivo].
Tang D; Mao A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):775-9. PubMed ID: 23016434
[TBL] [Abstract][Full Text] [Related]
8. Delivery of siRNA therapeutics: barriers and carriers.
Wang J; Lu Z; Wientjes MG; Au JL
AAPS J; 2010 Dec; 12(4):492-503. PubMed ID: 20544328
[TBL] [Abstract][Full Text] [Related]
9. Nanovehicle-based Small Interfering RNA (siRNA) Delivery for Therapeutic Purposes: A New Molecular Approach in Pharmacogenomics.
Akhtari J; Tafazoli A; Mehrad-Majd H; Mahrooz A
Curr Clin Pharmacol; 2018; 13(3):173-182. PubMed ID: 29992895
[TBL] [Abstract][Full Text] [Related]
10. Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy.
Mishra DK; Balekar N; Mishra PK
Drug Deliv Transl Res; 2017 Apr; 7(2):346-358. PubMed ID: 28050890
[TBL] [Abstract][Full Text] [Related]
11. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.
DeVincenzo JP
Antivir Ther; 2012; 17(1 Pt B):213-25. PubMed ID: 22311654
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.
Draz MS; Fang BA; Zhang P; Hu Z; Gu S; Weng KC; Gray JW; Chen FF
Theranostics; 2014; 4(9):872-92. PubMed ID: 25057313
[TBL] [Abstract][Full Text] [Related]
13. Design of Highly Potent Lipid-Functionalized Peptidomimetics for Efficient in Vivo siRNA Delivery.
Xiao H; Altangerel A; Gerile G; Wu Y; Baigude H
ACS Appl Mater Interfaces; 2016 Mar; 8(12):7638-45. PubMed ID: 26964858
[TBL] [Abstract][Full Text] [Related]
14. Delivery strategies for siRNA-mediated gene silencing.
Gilmore IR; Fox SP; Hollins AJ; Akhtar S
Curr Drug Deliv; 2006 Apr; 3(2):147-5. PubMed ID: 16611001
[TBL] [Abstract][Full Text] [Related]
15. Bio-inspired materials in drug delivery: Exploring the role of pulmonary surfactant in siRNA inhalation therapy.
De Backer L; Cerrada A; Pérez-Gil J; De Smedt SC; Raemdonck K
J Control Release; 2015 Dec; 220(Pt B):642-50. PubMed ID: 26363301
[TBL] [Abstract][Full Text] [Related]
16. In vivo application of RNA interference: from functional genomics to therapeutics.
Lu PY; Xie F; Woodle MC
Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
[TBL] [Abstract][Full Text] [Related]
17. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
[TBL] [Abstract][Full Text] [Related]
18. Potential applications of RNA interference-based therapeutics in the treatment of cardiovascular disease.
Hassan A
Recent Pat Cardiovasc Drug Discov; 2006 Jun; 1(2):141-9. PubMed ID: 18221081
[TBL] [Abstract][Full Text] [Related]
19. Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting.
De Paula D; Bentley MV; Mahato RI
RNA; 2007 Apr; 13(4):431-56. PubMed ID: 17329355
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle-based delivery system for application of siRNA in vivo.
Wang Y; Li Z; Han Y; Liang LH; Ji A
Curr Drug Metab; 2010 Feb; 11(2):182-96. PubMed ID: 20359287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
